Subgrouping by gene expression profiles to improve relapse risk prediction in paediatric B‐precursor acute lymphoblastic leukaemia
Abstract Relapsed acute lymphoblastic leukaemia (ALL) remains a prevalent paediatric cancer and one of the most common causes of mortality from malignancy in children. Tailoring the intensity of therapy according to early stratification is a promising strategy but remains a major challenge due to he...
Main Authors: | Qingsheng Huang, Jiayong Zhong, Huan Gao, Kuanrong Li, Huiying Liang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-06-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.3842 |
Similar Items
-
The clinical significance of current laboratory and other prognostic indicators in the management of South African children with Precursor B cell acute lymphoblastic leukaemia
by: Schapkaitz, Elise
Published: (2009) -
A retrospective study of acute lymphoblastic leukaemia in Paediatric patients at Dr George Mukhari Hospital (2003-2007)
by: Swanepoel, Yolande
Published: (2010) -
Immunoglobulin genes and T-cell receptors as molecular markers in children with acute lymphoblastic leukaemia
by: Lazić Jelena, et al.
Published: (2009-01-01) -
Targeted Therapy in Acute Lymphoblastic Leukaemia
by: Ross Salvaris, et al.
Published: (2021-07-01) -
Comparing morphology, flow cytometry and molecular genetics in the assessment of minimal residual disease in children with B-acute lymphoblastic leukaemia (B-ALL)
by: Candice L. Hendricks, et al.
Published: (2019-10-01)